References
- O'Leary JG, Greenberg CS, Patton HM, et al. AGA clinical practice update: coagulation in cirrhosis. Gastroenterology. 2019;157(1):34–43 e31.
- Tanaka KA, Key NS, Levy JH. Blood coagulation: hemostasis and thrombin regulation. Anesth Analg. 2009;108(5):1433–1446.
- Zermatten MG, Fraga M, Moradpour D, et al. Hemostatic alterations in patients with cirrhosis: from primary hemostasis to fibrinolysis. Hepatology. 2020;71(6):2135–2148.
- Tripodi A, Primignani M, Chantarangkul V, et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology. 2009;137(6):2105–2111.
- Davenport A, Sheikh MF, Lamb E, et al. Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit? Kidney Int. 2017;92(5):1058–1070.
- Egerod Israelsen M, Gluud LL, Krag A. Acute kidney injury and hepatorenal syndrome in cirrhosis. J Gastroenterol Hepatol. 2015;30(2):236–243.
- Belcher JM, Sanyal AJ, Peixoto AJ, et al. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology. 2014;60(2):622–632.
- Moller S, Bendtsen F. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis. Liver Int. 2018;38(4):570–580.
- Villanueva C, Lopez-Balaguer JM, Aracil C, et al. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis. J Hepatol. 2004;40(5):757–765.
- Stahl E, Karlberg BE, Rammer L. Fibrin deposition in the kidney and renal blood flow during intravascular coagulation in the rat: influence of the renin-angiotensin system. Clin Sci. 1982;62(1):35–41.
- Zanetto A, Rinder HM, Campello E, et al. Acute kidney injury in decompensated cirrhosis is associated with both hypo-coagulable and hyper-coagulable features. Hepatology. 2020;72(4):1327–1340.
- Xu Z, Cheng B, Fu S, et al. Coagulative biomarkers on admission to the ICU predict acute kidney injury and mortality in patients with septic shock caused by intra-abdominal infection. Infect Drug Resist. 2019;12:2755–2764.
- Hingorani SR, Seidel K, Pao E, et al. Markers of coagulation activation and acute kidney injury in patients after hematopoietic cell transplantation. Bone Marrow Transplant. 2015;50(5):715–720.
- Bhatraju PK, Zelnick LR, Herting J, et al. Identification of acute kidney injury subphenotypes with differing molecular signatures and responses to vasopressin therapy. Am J Respir Crit Care Med. 2019;199(7):863–872.
- [Chinese guidelines on the management of liver cirrhosis]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 2019;27:846–865.
- Simonetto DA, Gines P, Kamath PS. Hepatorenal syndrome: pathophysiology, diagnosis, and management. BMJ. 2020;370:m2687.
- Nayak SL, Maiwall R, Nandwani A, et al. Management of acute kidney injury in cirrhosis. Hepatol Int. 2013;7(3):813–819.
- Angeli P, Garcia-Tsao G, Nadim MK, et al. News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the international club of ascites (Ica) consensus document. J Hepatol. 2019;71(4):811–822.
- Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the international club of ascites. J Hepatol. 2015;62(4):968–974.
- Mindikoglu AL, Pappas SC. New developments in hepatorenal syndrome. Clin Gastroenterol Hepatol. 2018;16(2):162–177 e161.
- Amin AA, Alabsawy EI, Jalan R, et al. Epidemiology, pathophysiology, and management of hepatorenal syndrome. Semin Nephrol. 2019;39(1):17–30.
- Matsuo S, Yasuda Y, Imai E, et al. Current status of estimated glomerular filtration rate (eGFR) equations for Asians and an approach to create a common eGFR equation. Nephrology. 2010;15(Suppl 2):45–48.
- Adam EH, Mohlmann M, Herrmann E, et al. Assessment of hemostatic profile in patients with mild to advanced liver cirrhosis. WJG. 2020;26(17):2097–2110.
- Agarwal B, Gatt A, Riddell A, et al. Hemostasis in patients with acute kidney injury secondary to acute liver failure. Kidney Int. 2013;84(1):158–163.
- Cheung KL, Bouchard BA, Cushman M. Venous thromboembolism, factor VIII and chronic kidney disease. Thromb Res. 2018;170:10–19.
- Catella J, Bertoletti L, Mismetti P, et al. Severe renal impairment and risk of bleeding during anticoagulation for venous thromboembolism. J Thromb Haemost. 2020;18(7):1728–1737.
- Lan-Ting H, You-Ming C, Li-Xin W, et al. Clinicopathological factors for tubulointerstitial injury in lupus nephritis. Clin Rheumatol. 2020;39(5):1617–1626.
- Luo E, Wang D, Liu B, et al. The value of d-Dimer level in predicting contrast-induced acute kidney injury in patients with acute ST-Segment elevation myocardial infarction after PCI. Clin Appl Thromb Hemost. 2020;26:1076029620944492.
- Lin KY, Chen HC, Jiang H, et al. Predictive value of admission D-dimer for contrast-induced acute kidney injury and poor outcomes after primary percutaneous coronary intervention. BMC Nephrol. 2020;21(1):90.
- Wang B, Jiang Q, Wu X. Association of D-dimers with acute kidney injury in pregnant women: a retrospective study. J Int Med Res. 2020;48(11):300060520966899.
- Wardle EN, Taylor G. Fibrin breakdown products and fibrinolysis in renal disease. J Clin Pathol. 1968;21(2):140–146.
- Suarez-Alvarez B, Liapis H, Anders HJ. Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology. Lab Invest. 2016;96(4):378–390.
- Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med. 2010;38(2 Suppl):S26–S34.
- Boesen EI, Krishnan KR, Pollock JS, et al. ETA activation mediates angiotensin II-induced infiltration of renal cortical T cells. J Am Soc Nephrol. 2011;22(12):2187–2192.
- Alehagen U, Aaseth J, Lindahl TL, et al. Dietary supplementation with selenium and coenzyme Q10 prevents increase in plasma D-Dimer while lowering cardiovascular mortality in an elderly Swedish population. Nutrients. 2021;13(4):1344.
- Lange CM. Systemic inflammation in hepatorenal syndrome – a target for novel treatment strategies? Liver Int. 2019;39(7):1199–1201.
- Sole C, Sola E, Huelin P, et al. Characterization of inflammatory response in hepatorenal syndrome: relationship with kidney outcome and survival. Liver Int. 2019;39(7):1246–1255.
- Kalambokis GN, Tsiakas I, Christaki M, et al. Systemic hemodynamic response to terlipressin predicts development of hepatorenal syndrome and survival in advanced cirrhosis. Eur J Gastroenterol Hepatol. 2018;30(6):659–667.
- Zhang S, He LL, Wang XH, et al. A novel scoring model for predicting mortality risk in patients with cirrhosis and hepatorenal syndrome. Eur J Gastroenterol Hepatol. 2018;30(8):938–943.
- Park J, Kim SU, Choi HJ, et al. Predictive role of the D-Dimer level in acute kidney injury in living donor liver transplantation: a retrospective observational cohort study. J Clin Med. 2022;11:450.